Literature DB >> 19754464

Knockout mice in understanding the mechanism of action of lithium.

Galila Agam1, Yuly Bersudsky, Gerard T Berry, Diederik Moechars, Yael Lavi-Avnon, R H Belmaker.   

Abstract

Lithium inhibits IMPase (inositol monophosphatase) activity, as well as inositol transporter function. To determine whether one or more of these mechanisms might underlie lithium's behavioural effects, we studied Impa1 (encoding IMPase) and Smit1 (sodium-myo-inositol transporter 1)-knockout mice. In brains of adult homozygous Impa1-knockout mice, IMPase activity was found to be decreased; however, inositol levels were not found to be altered. Behavioural analysis indicated decreased immobility in the forced-swim test as well as a strongly increased sensitivity to pilocarpine-induced seizures. These are behaviours robustly induced by lithium. In homozygous Smit1-knockout mice, free inositol levels were decreased in the frontal cortex and hippocampus. These animals behave like lithium-treated animals in the model of pilocarpine seizures and in the Porsolt forced-swim test model of depression. In contrast with O'Brien et al. [O'Brien, Harper, Jove, Woodgett, Maretto, Piccolo and Klein (2004) J. Neurosci. 24, 6791-6798], we could not confirm that heterozygous Gsk3b (glycogen synthase kinase 3beta)-knockout mice exhibit decreased immobility in the Porsolt forced-swim test or decreased amphetamine-induced hyperactivity in a manner mimicking lithium's behavioural effects. These data support the role of inositol-related processes rather than GSK3beta in the mechanism of the therapeutic action of lithium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754464     DOI: 10.1042/BST0371121

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  20 in total

1.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

Review 2.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

Review 3.  Decoding neuroproteomics: integrating the genome, translatome and functional anatomy.

Authors:  Robert R Kitchen; Joel S Rozowsky; Mark B Gerstein; Angus C Nairn
Journal:  Nat Neurosci       Date:  2014-10-28       Impact factor: 24.884

4.  In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.

Authors:  Seisuke Fujita; Tetsuo Ohnishi; Shujiro Okuda; Ryo Kobayashi; Satoshi Fukuno; Daisuke Furuta; Takeshi Kikuchi; Takeo Yoshikawa; Norihisa Fujita
Journal:  J Mol Model       Date:  2011-01-07       Impact factor: 1.810

Review 5.  Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?

Authors:  Gerard T Berry
Journal:  J Inherit Metab Dis       Date:  2011-01-19       Impact factor: 4.982

6.  Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.

Authors:  Michelle Mo; Ildiko Erdelyi; Klara Szigeti-Buck; Jennifer H Benbow; Barbara E Ehrlich
Journal:  FASEB J       Date:  2012-08-13       Impact factor: 5.191

7.  Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.

Authors:  Nisha Singh; Ann L Sharpley; Uzay E Emir; Charles Masaki; Mohammad M Herzallah; Mark A Gluck; Trevor Sharp; Catherine J Harmer; Sridhar R Vasudevan; Philip J Cowen; Grant C Churchill
Journal:  Neuropsychopharmacology       Date:  2015-11-23       Impact factor: 7.853

Review 8.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

9.  A safe lithium mimetic for bipolar disorder.

Authors:  Nisha Singh; Amy C Halliday; Justyn M Thomas; Olga V Kuznetsova; Rhiannon Baldwin; Esther C Y Woon; Parvinder K Aley; Ivi Antoniadou; Trevor Sharp; Sridhar R Vasudevan; Grant C Churchill
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Diminished Myoinositol in Ventromedial Prefrontal Cortex Modulates the Endophenotype of Impulsivity.

Authors:  Bianca Jupp; Steve J Sawiak; Bastiaan van der Veen; Suzanne Lemstra; Chiara Toschi; Rebecca L Barlow; Anton Pekcec; Tom Bretschneider; Janet R Nicholson; Trevor W Robbins; Jeffrey W Dalley
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.